LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE:GKOS) announced today that it has entered into a settlement agreement with Transcend Medical, Inc. to resolve all existing patent litigation between the two companies. Under the settlement agreement, Glaukos grants Transcend a covenant not to sue Transcend for patent infringement in connection with Transcend’s CyPass Micro-Stent devices, appliers and delivery systems. In exchange, Transcend grants Glaukos a covenant not to challen
A recent expose examined the practice of surgeons double-booking surgery–and why it is wrong. Medscape
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today report…
NEW YORK — With up to 20% to 25% of patients having either ocular hypertension or glaucoma, it is important for cataract surgeons to evaluate new glaucoma procedures, according to a speaker here.“What used to be a disease we needed to manage for about 15 years is now a disease we need to manage for about 40 years, and because of that, we really want to take advantage of each of the steps that we have been taking for glaucoma patients,” Savak “Sev” Teymoorian, MD, MBA, said at OSN New (Read more...)
Allergan today announced that it has been approached by Pfizer and is in preliminary discussions regarding a potential business combination transaction, according to a press release.“No agreement has been reached and there can be no certainty that these discussions will lead to a transaction, or as to the terms on which a transaction, if any, might be agreed,” Allergan stated in the release.
Femtosecond laser-assisted cataract surgery is becoming more widely available, but its role is still controversial. Where does this technology fit in to resident surgical training? International Ophthalmology Clinics